Abstract
Accumulating evidence indicates that microRNAs (miRNAs) have a vital effect on lung adenocarcinoma. However, the contributions and possible mechanisms of miR-181c-5p to lung adenocarcinoma remain largely unclear. Our objective is to clarify the potential mechanism by which miR-181c-5p regulates lung adenocarcinoma progression. RT-qPCR was performed to determine the levels of miR-181c-5p in lung adenocarcinoma tissues and cells. CCK-8 and Transwell assays were conducted to evaluate the viability, migration, and invasion of H460 cells, respectively. The putative target association between miR-181c-5p and the Parkin gene (PRKN) was predicted using miRDB and confirmed by dual-luciferase reporter assay. MiR-181c-5p expression was found to be up-regulated in both lung adenocarcinoma tissues and cells. Suppression of miR-181c-5p resulted in the inhibition of viability, migration, and invasion in lung adenocarcinoma cells. PRKN level was negatively related to miR-181c-5p expression and mediated with the miR-181c-5p’s functions on lung adenocarcinoma progression. MiR-181c-5p regulates lung adenocarcinoma progression via targeting PRKN, indicating miR-181c-5p is expected to be a diagnostic and predictive marker for lung adenocarcinoma, providing new insights into the development of treatment strategies for lung adenocarcinoma.
Similar content being viewed by others
Data Availability
All data generated or analyzed during this study are included in this published article.
References
Araya J, Tsubouchi K, Sato N, Ito S, Minagawa S, Hara H et al (2019) PRKN-regulated mitophagy and cellular senescence during COPD pathogenesis. Autophagy 15(3):510–526
Azizi Dargahlou S, Iriti M, Pouresmaeil M, Goh LPW (2023) MicroRNAs; their therapeutic and biomarker properties. Cell Mol Biomed 3(2):73–88
Bade BC, Dela Cruz CS (2020) Lung cancer 2020: epidemiology, etiology, and prevention. Clin Chest Med 41(1):1–24
Beer DG, Kardia SL, Huang CC, Giordano TJ, Levin AM, Misek DE et al (2002) Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nat Med 8(8):816–824
Betel D, Wilson M, Gabow A, Marks DS, Sander C (2008) The microRNA.org resource: targets and expression. Nucleic Acids Res. https://doi.org/10.1093/nar/gkm995
Chen Z, Teng X, Zhang J, Huang K, Shen Q, Cao H et al (2019a) Molecular features of lung adenocarcinoma in young patients. BMC Cancer 19(1):777
Chen Y, Chen HN, Wang K, Zhang L, Huang Z, Liu J et al (2019b) Ketoconazole exacerbates mitophagy to induce apoptosis by downregulating cyclooxygenase-2 in hepatocellular carcinoma. J Hepatol 70(1):66–77
Chen Y, Zhang W, Shen L, Kadier A, Huang J, Wang R et al (2020) Downregulation of long noncoding RNA LUCAT1 suppresses the migration and invasion of bladder cancer by targeting miR-181c-5p. Biomed Res Int 2020:4817608
Chen C, Tao Z, Li Y, Li J, Xu Y (2022) MicroRNA214 expression inhibits HCC cell proliferation through PTK2b/ Pyk2. Cell Mol Biol (noisy-Le-Grand) 68(1):20–25
Costa DK, Huckestein BR, Edmunds LR, Petersen MC, Nasiri A, Butrico GM et al (2016) Reduced intestinal lipid absorption and body weight-independent improvements in insulin sensitivity in high-fat diet-fed Park2 knockout mice. Am J Physiol Endocrinol Metab 311(1):E105–E116
Denisenko TV, Budkevich IN, Zhivotovsky B (2018) Cell death-based treatment of lung adenocarcinoma. Cell Death Dis 9(2):117
Edmunds LR, Huckestein BR, Kahn M, Zhang D, Chu Y, Zhang Y et al (2019) Hepatic insulin sensitivity is improved in high-fat diet-fed Park2 knockout mice in association with increased hepatic AMPK activation and reduced steatosis. Physiol Rep 7(21):e14281
Edmunds LR, Xie B, Mills AM, Huckestein BR, Undamatla R, Murali A et al (2020) Liver-specific Prkn knockout mice are more susceptible to diet-induced hepatic steatosis and insulin resistance. Mol Metab 41:101051
Fan J, Dai X, Wang Z, Huang B, Shi H, Luo D et al (2019) Concomitant EGFR mutation and EML4-ALK rearrangement in lung adenocarcinoma is more frequent in multifocal lesions. Clin Lung Cancer 20(4):e517–e530
Gao ZQ, Wang JF, Chen DH, Ma XS, Yang W, Zhe T et al (2018) Long non-coding RNA GAS5 antagonizes the chemoresistance of pancreatic cancer cells through down-regulation of miR-181c-5p. Biomed Pharmacother 97:809–817
Ge L, Cai Y, Ying F, Liu H, Zhang D, He Y et al (2019) miR-181c-5p exacerbates hypoxia/reoxygenation-induced cardiomyocyte apoptosis via targeting PTPN4. Oxid Med Cell Longev 2019:1957920
Hasan A, Ali M, Redha AA (2022) Investigating the structure and function of long non-coding RNA (LncRNA) and its role in cancer. Cell Mol Biomed 2:245–253
Iorio MV, Croce CM (2012) MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A Compr Rev EMBO Mol Med 4(3):143–159
Klinge CM (2018) Non-coding RNAs in breast cancer: intracellular and intercellular communication. Noncoding RNA. https://doi.org/10.3390/ncrna4040040
Kohno T, Ichikawa H, Totoki Y, Yasuda K, Hiramoto M, Nammo T et al (2012) KIF5B-RET fusions in lung adenocarcinoma. Nat Med 18(3):375–377
Krol J, Loedige I, Filipowicz W (2010) The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet 11(9):597–610
Li N, Cheng C, Wang T (2020) MiR-181c-5p mitigates tumorigenesis in cervical squamous cell carcinoma via targeting glycogen synthase kinase 3beta interaction protein (GSKIP). Onco Targets Ther 13:4495–4505
Li X, Su S, Ye D, Yu Z, Lu W, Liu L (2022) Hsa_circ_0020850 promotes the malignant behaviors of lung adenocarcinoma by regulating miR-326/BECN1 axis. World J Surg Oncol 20(1):13
Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25(4):402–408
Naghmana K, Othman Al S, Haider Majid H, Z., Ali M., Mohammad H. (2023) Comprehensive analysis of microRNA (miRNA) in cancer cells. Cell Mol Biomed 3:89–97
Niemira M, Collin F, Szalkowska A, Bielska A, Chwialkowska K, Reszec J et al (2019) Molecular signature of subtypes of non-small-cell lung cancer by large-scale transcriptional profiling: identification of key modules and genes by weighted gene co-expression network analysis (WGCNA). Cancers. https://doi.org/10.3390/cancers12010037)
Niu K, Fang H, Chen Z, Zhu Y, Tan Q, Wei D et al (2020) USP33 deubiquitinates PRKN/parkin and antagonizes its role in mitophagy. Autophagy 16(4):724–734
Ozdemir BC, Dotto GP (2017) Racial differences in cancer susceptibility and survival: more than the color of the skin? Trends Cancer 3(3):181–197
Rah A, Ar M, Hk A (2021) Molecular and clinical analysis of genes involved in gastric cancer. Cell Mol Biomed 1:138–146
Shen X, Li Y, Sun G, Guo D, Bai X (2018) miR-181c-3p and -5p promotes high-glucose-induced dysfunction in human umbilical vein endothelial cells by regulating leukemia inhibitory factor. Int J Biol Macromol 115:509–517
Skoulidis F, Goldberg ME, Greenawalt DM, Hellmann MD, Awad MM, Gainor JF et al (2018) STK11/LKB1 mutations and PD-1 inhibitor resistance in KRAS-mutant lung adenocarcinoma. Cancer Discov 8(7):822–835
Sliter DA, Martinez J, Hao L, Chen X, Sun N, Fischer TD et al (2018) Parkin and PINK1 mitigate STING-induced inflammation. Nature 561(7722):258–262
Song Q, Shang J, Yang Z, Zhang L, Zhang C, Chen J et al (2019) Identification of an immune signature predicting prognosis risk of patients in lung adenocarcinoma. J Transl Med 17(1):70
Tahmasebi E, Kaboudanian Ardestani A, Madihi N, Abbasiparashkouh Z, Abbasi Maleki S, Yazdanian M et al (2022) Evaluation of the current MicroRNAs expression levels as potential biomarkers in oral squamous cell carcinoma: evaluation of the current micrornas in OSCC. Cell Mol Biol (noisy-Le-Grand) 68(10):193–198
Wei W, Zhao X, Liu J, Zhang Z (2021) Downregulation of LINC00665 suppresses the progression of lung adenocarcinoma via regulating miR-181c-5p/ZIC2 axis. Aging (albany NY) 13(13):17499–17515
Yan C, Gong L, Chen L, Xu M, Abou-Hamdan H, Tang M et al (2020) PHB2 (prohibitin 2) promotes PINK1-PRKN/Parkin-dependent mitophagy by the PARL-PGAM5-PINK1 axis. Autophagy 16(3):419–434
Zhang L, Zhang Z, Yu Z (2019) Identification of a novel glycolysis-related gene signature for predicting metastasis and survival in patients with lung adenocarcinoma. J Transl Med 17(1):423
Zhi W, Feng Q, Mingzhu Z (2022) MiR-140 targets Wnt1 to inhibit the proliferation and enhance drug sensitivity in osteosarcoma cells. Cell Mol Biol (noisy-Le-Grand) 68(1):140–146
Zhu X, Lu X (2019) MiR-423-5p inhibition alleviates cardiomyocyte apoptosis and mitochondrial dysfunction caused by hypoxia/reoxygenation through activation of the wnt/beta-catenin signaling pathway via targeting MYBL2. J Cell Physiol 234(12):22034–22043
Acknowledgements
We deeply appreciate the support of all participants.
Funding
Not applicable.
Author information
Authors and Affiliations
Contributions
JW and YH conceived and designed the study. ML and MW performed the literature search and data extraction. JY and DL analyzed the data. JW drafted the manuscript. YH finalized the manuscript. All the authors participated in the experiments and read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflicts of interest
The authors state that there is no conflict of interest.
Ethical Approval
The experimental protocol was established, according to the ethical guidelines of the Helsinki Declaration and was approved by the Ethics Committee of the Yantai Laiyang Central Hospital.
Informed Consent
The analysis was performed according to the principles of the Helsinki Declaration. Written informed consent was obtained from all patients.
Consent for Publication
The authors give consent to the publication in the journal.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Wang, J., Li, M., Wang, M. et al. MiR-181c-5p Regulates Lung Adenocarcinoma Progression via Targeting PRKN. Biochem Genet 62, 1103–1114 (2024). https://doi.org/10.1007/s10528-023-10459-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10528-023-10459-w